Tactile Systems Technology Inc
NASDAQ:TCMD
Gross Margin
Tactile Systems Technology Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
318.4m USD |
51%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
216.2B USD |
56%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.1B USD |
67%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
134.9B USD |
68%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
131.7B USD |
64%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.7B USD |
66%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
45%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.4B EUR |
38%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
40.6B USD |
79%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
258.3B CNY |
64%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
31.3B USD |
58%
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Tactile Systems Technology Inc's most recent financial statements, the company has Gross Margin of 51.4%.
You don't have any saved screeners yet